Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations
Shots:
- The company has launched the cobas SARS-CoV-2 variant set 1 test to detect spike mutations in virus variants including UK (B.1.1.7)- South Africa (B.1.351)- and Brazil (P.1)
- The accurate detection and differentiation of SARS-CoV-2 mutations can aid in assessing the spread of circulating variants and monitor their potential impact on diagnostics- vaccines and therapeutics
- The cobas SARS-CoV-2 variant set 1 test runs on the high-volume cobas 6800/8800 systems and is for research purposes only. The periodic assessments against emerging variants demonstrated Roche’s test is accurate and effective
Ref: Roche | Image: Roche
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com